---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-113589"
form_type: "8-K"
ticker: "OGN"
cik: "0001821825"
company_name: "Organon & Co."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T00:52:07.069474+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Organon Q3 revenue $1.52B, adj. EPS $0.87; narrows & lowers FY2023 guidance

## Summary
- Revenue $1,519M (-1% YoY); diluted EPS $0.23; non-GAAP adj. diluted EPS $0.87.
- Women's Health -7% ex-FX; Biosimilars +10% ex-FX; Established Brands +3% ex-FX.
- Board declares quarterly dividend $0.28 per share, unchanged.
- FY2023 revenue guidance narrowed to $6.15-6.25B (prev. $6.15-6.35B); adj. EBITDA margin 30.5-31.5% (prev. 31-33%).
- Adjusted EBITDA $447M, margin 29.4% vs 35.5% a year ago.

## SEC filing metadata
- accession: 0001104659-23-113589
- form_type: 8-K
- ticker: OGN
- cik: 0001821825
- company_name: Organon & Co.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821825/000110465923113589/0001104659-23-113589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821825/000110465923113589/tm2329655d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-113589
- JSON: https://secwatch.observer/filing/0001104659-23-113589.json
- Plain text: https://secwatch.observer/filing/0001104659-23-113589.txt

## Key facts
- Earnings Releases
  Organon & Co. reported third quarter ended September 30, 2023 results: revenue $1,519 million, net income $58 million, EPS $0.23. Guidance lowered.
  - Period: third quarter ended September 30, 2023
  - Revenue: $1,519 million
  - Net income: $58 million
  - EPS: $0.23
  - Guidance: lowered
  - Result: reported results
  source text: Organon Reports Results for the Third Quarter Ended September 30, 2023 • Third quarter 2023 revenue of $1,519 million • Third quarter 2023 diluted earnings per share of $0.23
  evidence_url: https://www.sec.gov/Archives/edgar/data/1821825/000110465923113589/0001104659-23-113589-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.